HC Wainwright Comments on InflaRxs FY2023 Earnings
| IFRX Stock | USD 1.15 0.10 8.00% |
Slightly above 62% of InflaRx NV's investor base is looking to short. The analysis of the overall investor sentiment regarding InflaRx NV suggests that many traders are alarmed. InflaRx NV's investing sentiment can be driven by a variety of factors including economic data, InflaRx NV's earnings reports, geopolitical events, and overall market trends.
InflaRx |
InflaRx Research analysts at HC Wainwright increased their FY2023 earnings estimates for shares of InflaRx in a report released on Thursday, November 2nd. HC Wainwright analyst E. White now anticipates that the company will post earnings per share of for the year, up from their previous forecast of .
Read at thelincolnianonline.com
 |
InflaRx NV Current Investor Sentiment
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use InflaRx NV's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward InflaRx NV.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
InflaRx NV Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards InflaRx NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
InflaRx NV Historical Investor Sentiment
Investor biases related to InflaRx NV's public news can be used to forecast risks associated with an investment in InflaRx. The trend in average sentiment can be used to explain how an investor holding InflaRx can time the market purely based on public headlines and social activities around InflaRx NV. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
InflaRx NV's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for InflaRx NV and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average InflaRx NV news discussions. The higher the estimate score, the more favorable the investor's outlook on InflaRx NV.
InflaRx NV Fundamental Analysis
We analyze InflaRx NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InflaRx NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InflaRx NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
InflaRx NV is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
InflaRx NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InflaRx NV stock to make a market-neutral strategy. Peer analysis of InflaRx NV could also be used in its relative valuation, which is a method of valuing InflaRx NV by comparing valuation metrics with similar companies.
Peers
InflaRx NV Related Equities
| PLX | Protalix Biotherapeutics | 4.03 | ||||
| DSGN | Design Therapeutics | 0.48 | ||||
| EWTX | Edgewise Therapeutics | 0.73 | ||||
| IKNA | Ikena Oncology | 0.75 | ||||
| EYPT | Eyepoint Pharmaceuticals | 1.35 | ||||
| ELDN | Eledon Pharmaceuticals | 1.76 | ||||
| ERAS | Erasca | 1.94 | ||||
| FULC | Fulcrum Therapeutics | 2.59 | ||||
| GLUE | Monte Rosa | 3.04 | ||||
| STOK | Stoke Therapeutics | 3.22 | ||||
| ABOS | Acumen Pharmaceuticals | 3.25 | ||||
| KRON | Kronos Bio | 3.49 | ||||
| HOWL | Werewolf Therapeutics | 3.74 | ||||
| KZR | Kezar Life | 4.09 | ||||
| SLS | Sellas Life | 4.31 | ||||
| CCCC | C4 Therapeutics | 4.89 | ||||
| GBIO | Generation Bio | 6.52 | ||||
| INZY | Inozyme Pharma | 7.07 | ||||
| PASG | Passage Bio | 7.32 | ||||
| RVPH | Reviva Pharmaceuticals | 7.34 |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.